Fcγ receptor IIIa single-nucleotide polymorphisms and haplotypes affect human IgG binding and are associated with lupus nephritis in African Americans

Arthritis and Rheumatology

Volumn 66, Issue 5, 2014, Pages 1291-1299

  Dong, Chaoling ^a,g   Ptacek, Travis S ^b   Redden, David T ^b   Zhang, Kui ^b   Brown, Elizabeth E ^b   Edberg, Jeffrey C ^b   McGwin Jr , Gerald ^b   Alarcõn, Graciela S ^b   Ramsey Goldman, Rosalind ^c   Reveille, John D ^d   Vilá, Luis M ^e   Petri, Michelle ^f   Qin, Aijian ^a   Wu, Jianming ^b,h   Kimberly, Robert P ^b  

^a YANGZHOU UNIVERSITY   (China)

^b The University of Alabama at Birmingham   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC GAMMA RECEPTOR IIIA; FC RECEPTOR; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ALLELE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; COPY NUMBER VARIATION; FCGR3A GENE; FLOW CYTOMETRY; GENE; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; LIGAND BINDING; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PYROSEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; ALLELES; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; IMMUNOGLOBULIN G; LUPUS NEPHRITIS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; RECEPTORS, IGG; RISK FACTORS;

EID: 84899718686     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38337     Document Type: Article

References (48)

1. International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40: 204-10.
2. Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 2011; 43: 1241-6.
3. Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H, et al. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 2012; 44: 517-21.
4. Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, Guiducci C, et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 2009; 41: 1313-8.
5. Radstake TR, Petit E, Pierlot C, van de Putte LB, Cornelis F, Barrera P,. Role of Fcγ receptors IIA, IIIA, and IIIB in susceptibility to rheumatoid arthritis. J Rheumatol 2003; 30: 926-33.
6. Su K, Wu J, Edberg JC, Li X, Ferguson P, Cooper GS, et al. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol 2004; 172: 7186-91.
7. Chen JY, Wang CM, Ma CC, Luo SF, Edberg JC, Kimberly RP, et al. Association of a transmembrane polymorphism of Fcγ receptor IIb (FCGR2B) with systemic lupus erythematosus in Taiwanese patients. Arthritis Rheum 2006; 54: 3908-17.
8. Chen JY, Wang CM, Wu JM, Ho HH, Luo SF,. Association of rheumatoid factor production with FcγRIIIa polymorphism in Taiwanese rheumatoid arthritis. Clin Exp Immunol 2006; 144: 10-6.
9. Koene HR, Kleijer M, Swaak AJ, Sullivan KE, Bijl M, Petri MA, et al. The FcγRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1813-8.
10. Lee YH, Ji JD, Song GG,. Fcγ receptor IIB and IIIB polymorphisms and susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Lupus 2009; 18: 727-34.
11. Morgan AW, Griffiths B, Ponchel F, Montague BM, Ali M, Gardner PP, et al. Fcγ receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups. Arthritis Rheum 2000; 43: 2328-34.
12. Niederer HA, Clatworthy MR, Willcocks LC, Smith KG,. FcγRIIB, FcγRIIIB, and systemic lupus erythematosus. Ann N Y Acad Sci 2010; 1183: 69-88.
13. Nieto A, Caliz R, Pascual M, Mataran L, Garcia S, Martin J,. Involvement of Fcγ receptor IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum 2000; 43: 735-9.
14. Shrestha S, Wiener HW, Olson AK, Edberg JC, Bowles NE, Patel H, et al. Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease. J Allergy Clin Immunol 2011; 128: 677-80.
15. Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, et al. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; 100: 1059-70.
16. Edberg JC, Langefeld CD, Wu J, Moser KL, Kaufman KM, Kelly J, et al. Genetic linkage and association of Fcγ receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. Arthritis Rheum 2002; 46: 2132-40.
17. Hong CH, Lee JS, Lee HS, Bae SC, Yoo DH,. The association between FcγRIIIB polymorphisms and systemic lupus erythematosus in Korea. Lupus 2005; 14: 346-50.
18. Karassa FB, Trikalinos TA, Ioannidis JP,. The role of FcγRIIA and IIIA polymorphisms in autoimmune diseases. Biomed Pharmacother 2004; 58: 286-91.
19. Lee YH, Ji JD, Song GG,. Associations between FCGR3A polymorphisms and susceptibility to rheumatoid arthritis: a metaanalysis. J Rheumatol 2008; 35: 2129-35.
20. Marques RB, Thabet MM, White SJ, Houwing-Duistermaat JJ, Bakker AM, Hendriks GJ, et al. Genetic variation of the Fcγ receptor 3B gene and association with rheumatoid arthritis. PLoS One 2010; 5.
21. Morgan AW, Barrett JH, Griffiths B, Subramanian D, Robinson JI, Keyte VH, et al. Analysis of Fcg receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B. Arthritis Res Ther 2006; 8: R5.
22. Morris DL, Roberts AL, Witherden AS, Tarzi R, Barros P, Whittaker JC, et al. Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus. Eur J Hum Genet 2010; 18: 1027-31.
23. Seligman VA, Suarez C, Lum R, Inda SE, Lin D, Li H, et al. The Fcγ receptor IIIA-158F allele is a major risk factor for the development of lupus nephritis among Caucasians but not non-Caucasians. Arthritis Rheum 2001; 44: 618-25.
24. Koene HR, Kleijer M, Algra J, Roos D, von dem Borne AE, de Haas M,. Fc γRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell FcγRIIIa, independently of the FcγRIIIa-48L/R/H phenotype. Blood 1997; 90: 1109-14.
25. Salmon JE, Ng S, Yoo DH, Kim TH, Kim SY, Song GG,. Altered distribution of Fcγ receptor IIIA alleles in a cohort of Korean patients with lupus nephritis. Arthritis Rheum 1999; 42: 818-9.
26. Karassa FB, Trikalinos TA, Ioannidis JP,. The FcγRIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. Kidney Int 2003; 63: 1475-82.
27. Li LH, Yuan H, Pan HF, Li WX, Li XP, Ye DQ,. Role of the Fcγ receptor IIIA-V/F158 polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Scand J Rheumatol 2010; 39: 148-54.
28. Brun JG, Madland TM, Vedeler CA,. Immunoglobulin G Fc-receptor (FcγR) IIA, IIIA, and IIIB polymorphisms related to disease severity in rheumatoid arthritis. J Rheumatol 2002; 29: 1135-40.
29. Kastbom A, Ahmadi A, Soderkvist P, Skogh T,. The 158V polymorphism of Fcγ receptor type IIIA in early rheumatoid arthritis: increased susceptibility and severity in male patients (the Swedish TIRA project). Rheumatology (Oxford) 2005; 44: 1294-8.
30. Kyogoku C, Tsuchiya N, Matsuta K, Tokunaga K,. Studies on the association of Fcγ receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: evidence for a genetic interaction between HLA-DRB1 and FCGR3A. Genes Immun 2002; 3: 488-93.
31. Milicic A, Misra R, Agrawal S, Aggarwal A, Brown MA, Wordsworth BP,. The F158V polymorphism in FcγRIIIA shows disparate associations with rheumatoid arthritis in two genetically distinct populations. Ann Rheum Dis 2002; 61: 1021-3.
32. Morgan AW, Keyte VH, Babbage SJ, Robinson JI, Ponchel F, Barrett JH, et al. FcγRIIIA-158V and rheumatoid arthritis: a confirmation study. Rheumatology (Oxford) 2003; 42: 528-33.
33. Stewart-Akers AM, Cunningham A, Wasko MC, Morel PA,. FcγR expression on NK cells influences disease severity in rheumatoid arthritis. Genes Immun 2004; 5: 521-9.
34. Thabet MM, Huizinga TW, Marques RB, Stoeken-Rijsbergen G, Bakker AM, Kurreeman FA, et al. Contribution of Fcγ receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis. Ann Rheum Dis 2009; 68: 1775-80.
35. De Haas M, Koene HR, Kleijer M, de Vries E, Simsek S, van Tol MJ, et al. A triallelic Fcγ receptor type IIIA polymorphism influences the binding of human IgG by NK cell FcγRIIIa. J Immunol 1996; 156: 2948-55.
36. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
37. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
38. Ehrhardt GR, Davis RS, Hsu JT, Leu CM, Ehrhardt A, Cooper MD,. The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc Natl Acad Sci U S A 2003; 100: 13489-94.
39. Armour KL, Smith CS, Clark MR,. Expression of human FcγRIIIa as a GPI-linked molecule on CHO cells to enable measurement of human IgG binding. J Immunol Methods 2010; 354: 20-33.
40. Drescher B, Witte T, Schmidt RE,. Glycosylation of FcγRIII in N163 as mechanism of regulating receptor affinity. Immunology 2003; 110: 335-40.
41. Barrett JC, Fry B, Maller J, Daly MJ,. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
42. Edberg JC, Kimberly RP,. Cell type-specific glycoforms of FcγRIIIa (CD16): differential ligand binding. J Immunol 1997; 159: 3849-57.
43. Yamamoto K, Sugita N, Kobayashi T, Okuda K, Van De Winkel JG, Yoshie H,. Evidence for a novel polymorphism affecting both N-linked glycosylation and ligand binding of the IgG receptor IIIB (CD16). Tissue Antigens 2001; 57: 363-6.
44. Igura M, Kohda D,. Selective control of oligosaccharide transfer efficiency for the N-glycosylation sequon by a point mutation in oligosaccharyltransferase. J Biol Chem 2011; 286: 13255-60.
45. Zhang Y, Boesen CC, Radaev S, Brooks AG, Fridman WH, Sautes-Fridman C, et al. Crystal structure of the extracellular domain of a human FcγRIII. Immunity 2000; 13: 387-95.
46. Zhou M, Todd RF III, van de Winkel JG, Petty HR,. Cocapping of the leukoadhesin molecules complement receptor type 3 and lymphocyte function-associated antigen-1 with Fcγ receptor III on human neutrophils: possible role of lectin-like interactions. J Immunol 1993; 150: 3030-41.
47. Zhou Y, Wu J, Kucik DF, White NB, Redden DT, Szalai AJ, et al. Multiple lupus associated ITGAM variants alter Mac-1 function on neutrophils. Arthritis Rheum 2013; 65: 2907-16.
48. M (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 2008; 40: 152-4.